3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Multiple Myeloma
2
Lymphoma, B-Cell
2
Lymphoma
2
Neurotoxicity Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Hodgkin Disease
1
Cytokine Release Syndrome
1
Interventions
Vincristine
4
Radiotherapy
3
Procarbazine
3
Methotrexate
3
Cytarabine
3
Rituximab
2
Prednisolone
2
Cyclophosphamide
2
motexafin gadolinium
1
glutamic acid diethyl ester
1
glucarpidase
1
fludarabine phosphate
1
fludarabine
1
axicabtagene ciloleucel
1
Simvastatin
1
Neuropsychological Tests
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Interleukin 1 Receptor Antagonist Protein
1
Glutamine
1
Glutamic Acid
1
Etoposide
1
Doxorubicin
1
Dietary Supplements
1
Dexamethasone
1
Contrast Media
1
Bendamustine Hydrochloride
1
Baclofen
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurotoxicity Syndromes
×
Neuropsychological Tests
×
Lymphoid
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled